Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib for Desensitization in Living Kidney Donation
NCT01842074Phase 4Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib in Human Leukocyte Antigen Sensitization, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
bortezomib
03
Conditions
Human Leukocyte Antigen Sensitization
Beyond the preview
Go deeper on NCT01842074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842074.